Condition: Mitral Regurgitation Functional · Sponsor: Nyra Medical, Inc.
Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.
This description comes directly from the study's public registry record.
Jennifer Mischke, VP of Regulatory and Clinical · 888 397 8046 · jmischke@nyra-medical.com
Always discuss trial participation with your own doctor first.
| University of California, Davis | Sacramento, California, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| The Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07503236